Showing 1 - 20 results of 23 for search 'Romualdo Barroso-Sousa', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer by Sarah Sammons, Sarah Sammons, Sarah Sammons, Andrew Elliott, Romualdo Barroso-Sousa, Romualdo Barroso-Sousa, Saranya Chumsri, Antoinette R. Tan, George W. Sledge, Sara M. Tolaney, Sara M. Tolaney, Sara M. Tolaney, Evanthia T. Roussos Torres
Published 2023-08-01
Article -
5
Intoxicação grave por paraquat: achados clínicos e radiológicos em um sobrevivente Severe paraquat poisoning: clinical and radiological findings in a survivor by Fábio Fernandes Neves, Romualdo Barroso Sousa, Antônio Pazin-Filho, Palmira Cupo, Jorge Elias Júnior, Marcello Henrique Nogueira-Barbosa
Published 2010-08-01
Article -
6
Decreased levels of alpha-1-acid glycoprotein are related to the mortality of septic patients in the emergency department by Romualdo Barroso-Sousa, Romulo R. Lobo, Patricia R. Mendonca, Renan R. Memoria, Fernando Spiller, Fernando Q. Cunha, Antonio Pazin-Filho
Published 2013-01-01
Article -
7
Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications by Carlos Wagner S. Wanderley, Carlos Wagner S. Wanderley, Tatiana Strava Correa, Mariana Scaranti, Fernando Queiroz Cunha, Fernando Queiroz Cunha, Romualdo Barroso-Sousa
Published 2022-04-01
Article -
8
-
9
Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients by Romualdo Barroso-Sousa, Rodrigo R. Munhoz, Milena P. Mak, Leonardo G. Fonseca, Angelo B. S. Fede, Rudinei Diogo Marques Linck, Clovis R. Coelho, Camila M. V. Moniz, Ciro E. Souza, Carlos Dzik
Published 2014-12-01
Article -
10
Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia by Gil Cunha De Santis, Mirela de Barros Tamarozzi, Romualdo Barroso Sousa, Susana Elisa Moreno, Daniela Secco, Aglair Bergamo Garcia, Ana Sílvia Gouveia Lima, Lúcia Helena Faccioli, Roberto Passetto Falcão, Fernando Queirós Cunha, Eduardo Magalhães Rego
Published 2007-12-01
Article -
11
896 Characterizing macrophage heterogeneity in HR+/HER2- metastatic breast cancer reveals novel mechanisms of resistance by Sara M Tolaney, Tianyu Li, Elizabeth A Mittendorf, Sandro Santagata, Jennifer L Guerriero, Nabihah Tayob, Peter K Sorger, Madeline G Townsend, Kelly F Zheng, Kenichi Shimada, Molly DiLullo, Eileen Wrabel, Tanya Keenan, Romualdo Barroso-Sousa
Published 2023-11-01Article -
12
Patterns of immune-related adverse events in patients treated with immune checkpoint inhibitors: a Brazilian real-world analysis by Maria Paula Furtado Santos, Allan Andersson Lima Pereira, Luiza Nardin Weis, Ana Carolina de Aquino Diniz, Rodrigo Bovolin de Medeiros, Artur Katz, Igor Alexandre Protzner Morbeck, Gustavo dos Santos Fernandes, Rodrigo Ramela Munhoz, Romualdo Barroso-Sousa
Published 2022-12-01
Article -
13
Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study by Romualdo Barroso-Sousa, Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo G. Pastorello, Edward T. Richardson III, Deborah Dillon, Zohreh Amoozgar, Beth Overmoyer, Stuart J. Schnitt, Eric P. Winer, Elizabeth A. Mittendorf, Eliezer Van Allen, Dan G. Duda, Sara M. Tolaney
Published 2021-08-01
Article -
14
What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer? by Ana Carolina Rathsam Leite, Daniele Assad Suzuki, Allan Anderson Lima Pereira, Natalia Polidorio Machado, Romualdo Barroso-Sousa, Tatiana Strava Correa, Fernanda Cesar Moura, Igor Alexandre Protzner Morbeck, Brenda Pires Gumz, Luiza Dib Batista Bugiato Faria, Gustavo dos Santos Fernandes, Renata Lazari Sandoval
Published 2022-09-01
Article -
15
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil by Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, Luiza Lara Gadotti, Rodrigo Saddi, Leandro Jonata de Carvalho Oliveira, Rudinei Diogo Marques Linck, Marcelo Rocha de Souza Cruz, Romualdo Barroso-Sousa, Marina Sahade, Tatiana Strava Correa, Max Senna Mano, Daniele Assad Suzuki, Andrea Kazumi Shimada, Artur Katz
Published 2023-01-01
Article -
16
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial by Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle
Published 2024-03-01
Article -
17
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems by Marcelo Antonini, André Mattar, Denise Joffily Pereira da Costa Pinheiro, Isabela Bastos Maia, Marina Diógenes Teixeira, Andressa Gonçalves Amorim, Odair Ferraro, Larissa Chrispim de Oliveira, Marcellus do Nascimento Moreira Ramos, Francisco Pimentel Cavalcante, Felipe Zerwes, Marcelo Madeira, Romualdo Barroso-Sousa, Eduardo de Camargo Millen, Antonio Luiz Frasson, Fabricio Palermo Brenelli, Gil Facina, Rogério Fenile, Luiz Henrique Gebrim, Juliana Monte Real
Published 2025-04-01
Article -
18
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer by Paolo Tarantino, Hersh Gupta, Melissa E. Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana C. Garrido-Castro, Romualdo Barroso-Sousa, Brittany L. Bychkovsky, Simona DiLascio, Lynette Sholl, Laura MacConaill, Neal Lindeman, Bruce E. Johnson, Matthew Meyerson, Rinath Jeselsohn, Xintao Qiu, Rong Li, Henry Long, Eric P. Winer, Deborah Dillon, Giuseppe Curigliano, Andrew D. Cherniack, Sara M. Tolaney, Nancy U. Lin
Published 2023-11-01
Article -
19
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer by Paolo Tarantino, Hersh Gupta, Melissa E. Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana C. Garrido-Castro, Romualdo Barroso-Sousa, Brittany L. Bychkovsky, Simona DiLascio, Lynette Sholl, Laura MacConaill, Neal Lindeman, Bruce E. Johnson, Matthew Meyerson, Rinath Jeselsohn, Xintao Qiu, Rong Li, Henry Long, Eric P. Winer, Deborah Dillon, Giuseppe Curigliano, Andrew D. Cherniack, Sara M. Tolaney, Nancy U. Lin
Published 2023-12-01
Article -
20
Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer by Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, Jose Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Laura Testa, Romualdo Barroso-Sousa
Published 2024-08-01
Article